Graft-versus-host reactions in dermatology

Journal of the American Academy of Dermatology

Volumn 38, Issue 3, 1998, Pages 369-392

  Johnson, M L ^a   Farmer, E R ^a  

^a KEESLER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETRETINATE; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOTOXIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; KETOTIFEN; METHOTREXATE; PENICILLAMINE; PENTOXIFYLLINE; PREDNISONE; TACROLIMUS; THALIDOMIDE; THYMOCYTE ANTIBODY;

AGE DISTRIBUTION; ALLOGENIC BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; DISEASE COURSE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HLA TYPING; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFECTIOUS COMPLICATION; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PATHOPHYSIOLOGY; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; SEX DIFFERENCE; SKIN MANIFESTATION; TOPICAL DRUG ADMINISTRATION;

EID: 0031916424     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(98)70495-5     Document Type: Article

References (270)

1. ED Thomas RA Clift R. Storb Indications for marrow transplantation Annu Rev Med 35 1984 1 9
2. JLM Ferrara HJ. Deeg Graft-versus-host disease N Engl J Med 324 1991 667 674
3. LO Jacobson EK Marks MJ Robson E Gaston RE. Zirkle Effects of spleen protection on mortality following x-irradiation J Lab Clin Med 34 1949 1538 1543
4. LO Jacobson EL Simmons EK Marks MJ Robson WF Bethard OE. Gaston The role of the spleen in radiation injury and recovery J Lab Clin Med 35 1950 746 770
5. E Lorenz D Uphoff TR Reid E. Shelton Modification of irradiation injury in mice and guinea pigs by bone marrow injections J Natl Cancer Inst 12 1951 197 201
6. O Vos JAG Davids WWH Weyzen DW. Bekkum Evidence for the cellular hypothesis in radiation protection by bone marrow cells Acta Physiol Pharmacol Neerl 4 1956 482 486
7. RM Merwin CC. Congdon Repopulation of hematopoietic tissues and blood in lethally x-irradiated mice by homologous bone-marrow cells J Natl Cancer Inst 19 1957 875 884
8. DWH Barnes MJ Corp JF Loutit FE. Neal Treatment of murine leukemia with x-rays and homologous bone marrow: a preliminary communication Br Med J 2 1956 626 627
9. R Billingham L. Brent A simple method for inducing tolerance of skin homographs in mice Transplant Bull 4 1957 67 71
10. M. Simonsen The impact on the developing embryo and newborn animal of adult homologous cells Acta Pathol Microbiol Scand 40 1957 480 500
11. ED Thomas HL Lochte WC Lu JW. Ferrebee Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy N Engl J Med 257 1957 491 496
12. FH Bach RJ Albertini P Joo JL Anderson MM. Bortin Bone marrow transplant in a patient with Wiskott-Aldrich syndrome Lancet 2 1968 1364 1366
13. RA Gatti HJ Meuwissen HD Allen R Hong RA. Good Immunologic reconstitution of sex-linked lymphopenic immunological deficiency Lancet 2 1968 1366 1369
14. J De Koning DW van Bekkum KA Dicke LJ Dooren J Radl JJ. Van Rood Transplantation of bone-marrow cells and fetal thymus in an infant with lymphopenic immunological deficiency Lancet 1 1969 1223 1227
15. MM. Bortin A compendium of reported human bone marrow transplants Transplantation 9 1970 571 587
16. FH Bach JJ. van Rood The major histocompatibility complex: genetics and biology (part 1) N Engl J Med 295 1976 806 813
17. ED Thomas R Storb RA Clift A Fefer FL Johnson PE Neiman Bone-marrow transplantation (part 1) N Engl J Med 292 1975 832 843
18. FH Bach JJ. van Rood The major histocompatibility complex genetics and biology (part 3) N Engl J Med 295 1976 927 936
19. ED. Thomas Marrow transplantation for malignant disease J Clin Oncol 1 1983 517 531
20. S Neudorf A Filipovich N Ramsey J. Kersey Prevention and treatment of acute GVHD Semin Hematol 21 1984 91 100
21. RP. Gale Graft-versus-host disease Immunol Rev 88 1985 193 214
22. RC Ash JT Casper CR Chitambar R Hansen N Bunin RL Truitt Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors N Engl J Med 322 1990 485 494
23. PJ. Martin Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors Bone Marrow Transplant 8 1991 217 223
24. BR. Hawkins Advances in human leukocyte antigens and transplantation Adv Clin Chem 30 1993 227 280
25. NKC Ramsey JH Kersey LL Robison PB McGlave WG Woods W Krivit A randomized study of the prevention of acute graft-versus-host disease N Engl J Med 306 1982 392 397
26. HJ. Deeg A guide to bone marrow transplantation 1992 Springer-Verlag Berlin 31 41
27. RE. Billingham The biology of graft-versus-host reactions Harvey Lect 62 1966-67 21 78
28. RG Desai WP. Creger Maternofetal passage of leukocytes and platelets in man Blood 21 1963 665 673
29. JI Kadowaki WW Zuelzer AJ Brough RI Thompson PV Woolley D. Gruber XX/XY lymphoid chimerism in congenital immunological deficiency syndrome with thymic alymphoplasia Lancet 2 1965 1152 1155
30. JH Turner N Wald W. Quinlivan Cytogenetic evidence concerning possible transplacental transfer of leukocytes in pregnant women Am J Obstet Gynecol 95 1966 831 833
31. SF Leitman PV. Holland Irradiation of blood products: indications and guidelines Transfusion 25 1985 293 300
32. G Alexander B. Portman Graft-versus-host disease after liver transplantation Hepatology 11 1990 144 145
33. VC Joysey H Wood S Ramsbottom H Morgan C Ford J Horsford Lymphocyte chimerism after organ transplantation Transplant Proc 24 1992 2519 2522
34. RJ. Davey Transfusion-associated graft-versus-host disease and the irradiation of blood components Immunol Invest 24 1995 431 434
35. + T cells J Acquir Immune Defic Syndr 6 1993 1224 1227
36. JA Habeshaw AG Dalgleish EF. Hounsell Absence of graft-versus-host disease in AIDS J Acquir Immune Defic Syndr 7 1994 1287 1288
37. G Torlontano P Di Bartolomeo G Di Girolamo F Angrilli P Verani MT Maggiorella AIDS-related complex treated by antiviral drugs and allogeneic bone marrow transplantation following conditioning protocol with busulphan, cyclophosphamide, and cyclosporin Haematologica 77 1992 287 290
38. LD Petz L Calhoun P Yam M Cecka G Schiller AR Faitlowicz Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion from a second-degree relative and a survey of predisposing factors Transfusion 33 1993 742 750
39. WL. Elkins Cellular immunology and the pathogenesis of graft-versus-host reactions Prog Allergy 15 1971 78 187
40. J Rappeport M Mihm EL Reinherz S Lopansri R. Parkman Acute graft-versus-host disease in recipients of bone marrow transplants from identical twin donors Lancet 2 1979 717 720
41. AF Hood GB Vogelsang LP Black ER Farmer GW. Santos Acute graft-versus-host disease: development following autologous and syngeneic bone marrow transplantation Arch Dermatol 123 1987 745 750
42. H Einsele G Ehnigner EM Schneider GF Kruger A Vallbracht R Dopfer High frequency of graft-versus-host–like syndrome following syngeneic bone marrow transplantation Transplantation 45 1988 579 585
43. AD Hess LR Horwitz MK. Laulis Cyclosporin-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo Transplant Proc 25 1993 1218 1221
44. R. Parkman Is chronic graft-versus-host disease an autoimmune disease? Curr Opin Immunol 5 1993 800 803
45. SJ Forman KG Blume ED. Thomas Bone marrow transplantation 1994 Blackwell Scientific Publications Boston 581 909
46. B. Shank Radiotherapeutic principles of bone marrow transplantation SJ Forman KG Blume ED Thomas Bone marrow transplantation. 1994 Blackwell Scientific Publications Boston 96 113
47. K. Atkinson Hemopoietic reconstruction posttransplant K Atkinson Clinical bone marrow transplantation. 1994 Cambridge University Press Cambridge 31 41
48. M. Boranic Transient graft-versus-host reactions in the treatment of leukemia in mice J Natl Cancer Inst 41 1968 421 437
49. PL Weiden N Flournoy ED Thomas R Prentice A Fefer CD Buckner Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts N Engl J Med 300 1979 1068 1073
50. PL Weiden KM Sullivan N Flournoy R Storb ED. Thomas Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation N Engl J Med 304 1981 1529 1533
51. DJ Bauer AF Hood TD. Horn Histologic comparison of autologous graft-versus-host reaction and cutaneous eruption of lymphocyte recovery Arch Dermatol 129 1993 855 858
52. TD. Horn Acute cutaneous eruptions after marrow ablation: Roses by other names? J Cutan Pathol 21 1994 385 392
53. AD Hess RJ. Jones Autologous graft-versus-host disease TR Spitzer A Mazumder Immunotherapy and bone marrow transplantation. 1995 Futura Publishing Co Armonk (NY) 59 70
54. AD Hess RC Jones GW. Santos Autologous graft-versus- host disease: mechanism and potential therapeutic effect Bone Marrow Transplant 12 Suppl 3 1993 S65 S69
55. D Niederwiesser B Eihl D. Nachbaur Graft-versus-host disease after autologous bone marrow transplantation: A realistic expectation? Wien Med Wochenschr 145 1995 25 27
56. N Pimpinelli M Santucci A. Bosi Localized scleroderma-like lesion in autologous bone marrow transplantation J Dermatol 2 1992 12 14
57. RW Martin ER Farmer VL Altomonte GB Vogelsang GW. Santos Lichenoid graft-versus-host disease in an autologous bone marrow transplant recipient Arch Dermatol 131 1995 333 335
58. AD Hess RJ Jones LE Morris SJ Noga AM Yeager GB Vogelsang Autologous graft-versus-host disease: a new frontier in immunotherapy Bone Marrow Transplant 10 Suppl 1 1992 16 21
59. AD Hess RJ Jones LE. Morris Autologous graft-versus-host disease: a novel approach for antitumor immunotherapy Human Immunology 34 1992 219 224
60. MJ Kennedy RJ. Jones Autologous graft-versus-host disease: immunotherapy of breast cancer after bone marrow transplantation Breast Cancer Res Treat 26 Suppl 1993 S31 S40
61. MJ. Kennedy Induced autologous graft-versus-host disease for the treatment of cancer Cancer Treat Rev 20 1994 97 103
62. AA Gaspari SF Cheng JF. DiPersio Roquinimex-induced graft-versus-host reaction after autologous bone marrow transplantation J Am Acad Dermatol 33 1995 711 717
63. HG. Klein Transfusion in transplant patients: the good, the bad, and the ugly J Heart Lung Transplant 12 Suppl 1993 S7 S12
64. BH Park RA Good J Gate B. Burke Fatal graft-versus- host reaction following transfusion of allogeneic blood and plasma in infants with combined immunodeficiency disease Transplant Proc 6 1974 385 387
65. AM Silverstein KL. Kraner Studies on the ontogenesis of the immune response J Sterzl Molecular and cellular basis of antibody formation. 1965 Academic Press New York 341 348
66. JL Naiman HH Punnett HW Lischner ML Destine JB. Arey Possible graft-versus-host reaction after intrauterine transfusion for Rh erythroblastosis fetalis N Engl J Med 281 1969 697 701
67. CS August AI Berkel S Driscoll E. Merler Onset of lymphocyte function in the developing human fetus Pediatr Res 5 1971 539 547
68. HJ Meuwissen RA Gatti PI Terasaki R Hong RA. Good Treatment of lymphopenic hypogammaglobulinemia and bone marrow aplasia by transplantation of allogeneic marrow N Engl J Med 281 1969 691 701
69. R Parkman D Mosier I Umanski W Cochran CB Carpenter FS. Rosen Graft-versus-host disease after intrauterine and exchange transfusions for hemolytic disease of the newborn N Engl J Med 290 1974 359 363
70. TA Seemayer RP. Bolande Thymic involution mimicking thymic dysplasia. A consequence of transfusion-induced graft-versus-host disease in a premature infant Arch Pathol Lab Med 104 1980 141 144
71. PG Beatty RA Clift EM Mickelson BB Nisperos N Flournoy PJ Martin Marrow transplantation from related donors other than HLA-identical siblings N Engl J Med 313 1985 765 771
72. D. Pietryga Prevention and treatment of acute graft-versus-host disease Am J Pediatr Hematol Oncol 15 1993 28 48
73. B DuPont SY. Yang Histocompatibility SJ Forman KB Blume ED Thomas Bone marrow transplantation. 1994 Blackwell Scientific Publications Boston 22 40
74. FH Bach JJ. van Rood The major histocompatibility complex: genetics and biology (part 2) N Engl J Med 295 1976 872 878
75. P. Martin Overview of marrow transplantation immunology SJ Forman KB Blume ED Thomas Bone marrow transplantation. 1994 Blackwell Scientific Publications Boston 16 21
76. HJ Deeg M. Cottler-Fox Clinical spectrum and pathophysiology of acute graft-versus-host disease SJ Burakoff HJ Deeg J Ferrara K Atkinson Graft-versus-host disease: immunology, pathophysiology, and treatment. 1990 Marcel Dekker New York 311 335
77. PG Beatty JA Hansen C Anasetti J Sanders CD Buckner R Storb Marrow transplantation from unrelated HLA-matched volunteer donors Transplant Proc 21 1989 2993 2994
78. C Anasetti D Amos PG Beatty FR Appelbaum W Bensinger CD Buckner Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma N Engl J Med 320 1989 197 204
79. RP Witherspoon HJ Deeg R. Storb Secondary malignancies after marrow transplantation for leukemia or aplastic anemia Transplant Sci 4 1994 33 41
80. P Herve J-Y Cahn PG. Beatty Graft-versus-host disease after bone marrow transplantation from donors other than HLA-identical siblings SJ Burakoff HJ Deeg J Ferrara K Atkinson Graft-versus-host disease: immunology, pathophysiology, and treatment. 1990 Marcel Dekker New York 425 454
81. JA Hansen PG Beatty C Anasetti RA Clift PJ Martin J Sanders Treatment of leukemia by marrow transplantation from donors other than HLA genotypically identical siblings RP Gale R Champlin Progress in bone marrow transplantation. 1987 Alan R Liss New York 667 675
82. R Storb ED. Thomas Graft-versus-host disease in dog and man: the Seattle experience Immunol Rev 88 1985 215 238
83. HG Klingeman R Storb A Fefer HG Deeg FR Appelbaum CD Buckner Bone marrow transplantation in patients aged 45 years and older Blood 67 1986 770 776
84. D Weisdorf R Hakke B Blazar W Miller P McGlave N Ramsey Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation Transplantation 51 1991 1197 1203
85. O Ringden T Paulin B Lonnqvist B. Nilsson An analysis of factors predisposing to chronic graft-versus-host disease Exp Hematol 13 1985 1062 1067
86. M Michallet B Corront JL Bosson J Reiffers G Marit D Maraninchi Risk factors for GVHD: study of 157 patients from Bordeaux, Grenoble, Marseille Bone Marrow Transplant 3 Suppl 1 1988 226
87. RP Gale MM Bortin DW van Bekkum JC Biggs KA Dicke E Gluckman Risk factors for acute graft-versus-host disease Br J Haematol 67 1987 397 406
88. HM Lazarus PF Coccia RH Herzig J Graham-Pole S Gross S Strandjord Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplantation patients Blood 64 1984 215 220
89. KM Sullivan HJ Deeg J Sanders A Klosterman D Amos H Shulman Hyperacute graft-vs-host disease in patients not given immunosuppression after allogeneic marrow transplantation Blood 67 1986 1172 1175
90. NA. Kernan T-cell depletion for prevention of graft-versus-host disease SJ Forman KB Blume ED Thomas Bone marrow transplantation. 1994 Blackwell Scientific Publications Boston 124 135
91. JM Goldman RP Gale MM Horowitz JC Biggs RE Champlin E Gluckman Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk for relapse associated with T-cell depletion Ann Intern Med 108 1988 806 814
92. PJ Martin JA Hansen B Torok-Storb D Durnam D Przepiorka J O'Quigley Graft failure in patients receiving T-cell depleted HLA-identical allogeneic marrow transplants Bone Marrow Transplant 3 1988 445 456
93. R Storb RH Rudolph HJ Kolb TC Graham E Mickelson V Erickson Marrow grafts between DL-A-matched canine littermates Transplantation 15 1973 92 100
94. P Herve P Tiberghien E Racadot E Plouvier JY. Cahn Prevention and treatment of acute graft-versus-host disease: new modalities Bone Marrow Transplant 11 Suppl 1 1993 103 106
95. KM Sullivan R Storb CD Buckner A Fefer L Fisher PL Weiden Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms N Engl J Med 320 1989 828 834
96. DWH Barnes JF. Loutit Spleen protection: the cellular hypothesis ZM Bacq Radiobiology symposium. 1955 Butterworth London 134 135
97. DE. Uphoff Genetic factors influencing irradiation protection by bone marrow J Natl Cancer Inst 19 1957 123 130
98. A Glazier PJ Tutschka ER Farmer GW. Santos Graft- versus-host disease in cyclosporin-A treated rats after syngeneic and autologous bone marrow reconstitution J Exp Med 158 1983 1 8
99. A Glazier PJ Tutschka ER. Farmer Studies on the immunobiology of syngeneic and autologous graft-versus-host disease in cyclosporin-treated rats Transplant Proc 15 1983 3035 3041
100. AD Hess L Horwitz WE Beschorner GW. Santos Induction of graft-versus-host disease–like syndrome in cyclosporin-treated rats after syngeneic bone marrow transplantation J Exp Med 161 1985 718 730
101. AD Hess GB Vogelsang J Heyd WE. Beschorner Cyclosporin-induced syngeneic graft-versus-host disease: assessment of T-cell differentiation Transplant Proc 19 1987 2683 2686
102. K. Atkinson Chronic graft-versus-host disease Bone Marrow Transplant 5 1990 69 82
103. JL. Ferrara Cytokine dysregulation as a mechanism of graft-versus-host disease Curr Opin Immunol 5 1993 794 799
104. JLM Ferrara S Abhyanker DG. Gilliland Cytokine storm of graft-versus-host disease: a critical effector role for IL-1 Transplant Proc 25 1993 1216 1217
105. BR Blazar PA Taylor A Panoskaltis-Mortari GS Gray DA. Vallera Coblockade of the LFA-1/ICAM and CD28/CTL4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully MHC-disparate donor grafts Blood 85 1995 2607 2618
106. V Rus A Svetic P Nguyen WC Gause CS. Via Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease: regulatory role of donor CD8+ T cells J Immunol 155 1995 2396 2406
107. AM Krensky A Weiss G Crabtree MM Davis P. Parham T-lymphocyte antigen interactions in transplant rejection N Engl J Med 322 1990 510 517
108. AL Appleton L. Sviland Current thoughts on the pathogenesis of graft-versus-host disease J Clin Pathol 46 1993 785 789
109. CS Via V Rus MK Gately FD. Finkelman IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic autoimmune graft-versus-host disease J Immunol 153 1994 4040 4047
110. RP Lowry T. Takeuchi The Th1, Th2 paradigm and transplantation tolerance 1994 CRC Press Boca Raton (FL) 37 42
111. DH Fowler K Kurasdawa R Smith MA Eckhaus RE. Gress Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice Blood 84 1994 3540 3549
112. + donor T-cells fail to induce experimental acute graft-versus-host disease J Immunol 155 1995 585 593
113. M. Theobald Allorecognition and graft-versus-host disease Bone Marrow Transplant 15 1995 489 498
114. M de Bueger E. Goulmy Human minor histocompatibility antigens Transpl Immunol 1 1993 28 38
115. E Goulmy R Schipper J Pool E Blokland JH Falkenburg J Vossen Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation N Engl J Med 334 1996 281 285
116. DC. Snover Acute and chronic graft-versus-host disease: histopathologic evidence for two pathologic mechanisms Hum Pathol 15 1984 202 205
117. GE Sale HM Shulman BB Gallucci ED. Thomas Young rete ridge keratinocytes are preferred targets in cutaneous graft-versus-host disease Am J Pathol 118 1985 278 287
118. FJ Guillen J Ferrara WW Hancock D Messadi E Fonferko SJ Burakoff Acute cutaneous graft-versus-host disease to minor histocompatibility antigens in a murine model: evidence that large granular lymphocytes are effector cells in the immune response Lab Invest 55 1986 35 42
119. A Barrett YZ. Jiang Immune responses to chronic myeloid leukemia Bone Marrow Transplant 9 1992 305 311
120. GE Sale M. Beauchamp Parafollicular hair bulge in human GVHD: a stem cell–rich primary target Bone Marrow Transplant 11 1993 223 225
121. HJ. Deeg Graft-versus-host disease: host and donor views Semin Hematol 30 Suppl 4 1993 110 118
122. GE Sale MD Beauchamp M. Akiyama Parafollicular bulges, but not hair bulb keratinocytes, are attacked in graft-versus-host disease of human skin Bone Marrow Transplant 14 1994 411 413
123. MR Jadus HT. Wepsic The role of cytokines in graft- versus-host reactions and disease Bone Marrow Transplant 10 1992 1 14
124. MS Tsoi R Storb E Santos ED. Thomas Anti-host cytotoxic cells in patients with acute graft-versus-host disease after HLA-identical marrow grafting Transplant Proc 15 1983 1484 1486
125. E Holler HJ Kolb A. Moller Increased levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation Blood 75 1990 1011 1016
126. E Kelemem J Szebeni GG. Petranyi Graft-versus-host disease in bone marrow transplantation: experimental, laboratory, and clinical contributions of the last few years Int Arch Allergy Immunol 102 1993 309 320
127. IA Lampert AG Suitters PM. Chisholm Expression of Ia antigen on epidermal keratinocytes in graft-versus-host disease Nature 293 1981 149 150
128. DW Mason M Dallman AN. Barclay Graft-versus-host disease induces expression of Ia antigen in rat epidermal cells and gut epithelium Nature 293 1981 150 151
129. IA Lampert G Janossy AJ Suitters M Bofill S Palmer E Gordon-Smith Immunological analysis of the skin in graft-versus-host disease Clin Exp Immunol 50 1982 123 131
130. L Sviland ADJ Pearson EJ Eastham MA Green PJ Hamilton SJ Proctor Class II antigen expression by keratinocytes and enterocytes: an early feature of graft-versus-host disease Transplantation 46 1988 402 406
131. PW Bland CV. Whiting Induction of MHC class II gene products in rat intestinal epithelium during graft-versus-host disease and effects on the immune function of the epithelium Immunology 75 1992 366 371
132. JL Rhoades ML Cibull JS Thompson PJ Henslee-Downey CD Jennings HP Sinn Role of natural killer cells in the pathogenesis of human acute graft-versus-host disease Transplantation 56 1993 113 120
133. A Acevedo J Aramburu J Lopez J Fernandez-Herrara JM Fernandez-Ranada M. Lopez-Botet Identification of natural killer (NK) cells in lesions of human cutaneous graft-versus-host disease: expression of a novel NK-associated surface antigen (Kp43) in mononuclear infiltrates J Invest Dermatol 97 1991 659 666
134. J Ferrara A Marion G Murphy S. Burakoff Acute graft- versus-host disease: pathogenesis and prevention with a monoclonal antibody in vivo Transplant Proc 19 1987 2662 2663
135. T Ghayur TA Seemayer PAL Konshavu JG Gartner WS. Lapp Graft-versus-host reactions in beige mice: an investigation of the role of host and donor natural killer cells in the pathogenesis of graft-versus-host disease Transplantation 44 1987 261 267
136. MC Dokhelar J Wiels M Lipinski C Tetaud A Devergie E Gluckman Natural killer (NK) cell activity in human bone marrow recipients: early appearance of peripheral NK cell activity in graft-versus-host disease Transplantation 31 1981 61 65
137. T Ghayur TA Seemayer WS. Lapp Prevention of murine graft-versus-host disease by inducing and eliminating ASGM1+ cells of donor origin Transplantation 45 1988 586 590
138. WJ Murphy CW Reynolds P Tiberghian DL. Longo Natural killer cells and bone marrow transplantation J Natl Cancer Inst 85 1993 1475 1482
139. J Ferrara SJ. Burakoff The pathophysiology of acute graft-versus-host disease in a murine bone marrow transplant model SJ Burakoff HJ Deeg J Ferrara K Atkinson Graft-versus-host disease: immunology, pathophysiology, and treatment. 1990 Marcel Dekker New York 9 29
140. AC Fischer WE Beschorner AD. Hess Requirements for the induction and adoptive transfer of cyclosporin-induced syngeneic graft-versus-host disease J Exp Med 169 1989 1031 1041
141. KM. Sullivan Chronic graft-versus-host disease R Champlin Bone marrow transplantation. 1990 Kluwer Academic Publishers Boston 79 98
142. LG. Lum Recapitulation of immune ontogeny: a vital component for the success of bone marrow transplantation R Champlin Bone marrow transplantation. 1990 Kluwer Academic Publishers Boston 27 54
143. MS Tsoi R Storb S Dobbs ED. Thomas Specific suppressor cells in graft-host tolerance of HLA-identical marrow transplantation Nature 292 1981 355 357
144. MS. Tsoi Immunologic mechanisms of graft-versus-host disease in man Transplantation 33 1982 459 464
145. HM. Shulman Pathology of chronic graft-versus-host disease SJ Burakoff HJ Deeg J Ferrara K Atkinson Graft-versus-host disease: immunology, pathophysiology, and treatment. 1990 Marcel Dekker New York 587 614
146. VN Kay PM Neuman J Kersey RW Goltz BD Baldridge AF Michael Identity of immune cells in graft-versus-host disease of the skin: analysis using monoclonal antibodies by indirect immunofluorescence Am J Pathol 116 1984 436 440
147. K. Atkinson Chronic graft-versus-host disease K Atkinson Clinical bone marrow transplantation: a reference textbook. 1994 Cambridge University Press Cambridge 312 324
148. R. Parkman Clonal analysis of murine graft-versus-host disease. I. Phenotypic and functional analysis of T-lymphocyte clones J Immunol 136 1986 3543 3548
149. Y DeClerck V Draper R. Parkman Clonal analysis of murine graft-versus-host disease. II. Leukokines that stimulate fibroblast proliferation and collagen synthesis in graft-versus-host disease J Immunol 136 1986 3549 3552
150. HN. Claman Mast cell depletion in chronic graft-versus- host disease J Invest Dermatol 84 1985 246 248
151. F. Levi-Schaffer Mast cell/fibroblast interactions in health and disease Chem Immunol 61 1995 161 185
152. RG Graw GN Rogentine BG Leventhal RH Halterman C Berard GP Herzig Graft-versus-host reaction complicating HL-A matched bone marrow transplantation Lancet 2 1970 1053 1055
153. CB Merritt DL Mann GN. Rogentine Cytotoxic antibody for epithelial cells in human graft-versus-host disease Nature 232 1971 638 639
154. HM Shulman KM Sullivan PL Weiden GB McDonald GE Striker GE Sale Chronic graft-versus-host syndrome in man: a long term clinicopathologic study of 20 Seattle patients Am J Med 69 1980 204 217
155. AM Rouquette-Gally D Boyeldieu E Gluckman N Abuaf A. Combrisson Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjogren's syndrome and scleroderma Br J Haematol 66 1987 45 47
156. J Lister H Messner AE Keystone R Miller MJ. Fritzler Autoantibody analysis of patients with graft-versus-host disease J Clin Lab Immunol 24 1987 19 23
157. S Ullman RL Spielvogel JH Kersey RW. Goltz Immunoglobulins and complement in skin in graft-versus-host disease [letter] Ann Intern Med 85 1976 205
158. JH Saurat JM Bonnetblanc E Gluckman L Didierjean A Bussell A. Puissant Skin antibodies in bone marrow transplanted patients Clin Exp Dermatol 1 1976 377 384
159. MS Tsoi R Storb E Jones PL Weiden H Shulman R Witherspoon Deposition of IgM and complement at the dermal-epidermal junction in acute and chronic graft-versus-host disease in man J Immunol 120 1978 1485 1492
160. ER Farmer TT Provost PJ Tutschka CH. Kallman Cutaneous graft-versus-host reactions: a prospective sequential immunopathologic study in man [abstract] Clin Res 27 1979 241A
161. AL Claudy D Schmitt F. Freycon Graft-versus-host reaction in the skin: histological, immunological, and ultrastructural studies Acta Derm Venereol (Stockh) 59 1979 7 25
162. GB Bolger KM Sullivan AM Spence FR Appelbaum R Johnston JE Sanders Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host disease Neurology 36 1986 1087 1091
163. C Anasetti W Rybka KM Sullivan M Banaji SJ. Slichter Graft-versus-host disease is associated with autoimmune-like thrombocytopenia Blood 73 1989 1054 1058
164. R Sorokin H Kimura K Schorder DH Wilson DB. Wilson Cyclosporin-induced autoimmunity. Conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats J Exp Med 164 1986 1615 1625
165. H Reynaert A De Coninck A-M Neven B Van Camp R. Schots Chemotherapy-induced acral erythema and acute graft-versus-host disease after allogeneic bone marrow transplantation Bone Marrow Transplant 10 1992 185 187
166. WE Beschorner JF Nammorim AD Hess CA Shinn GW. Santos Cyclosporin and the thymus: immuno-pathology Am J Pathol 126 1987 487 496
167. WE Beschorner DL Suresch T Shinozawa GW Santos AD. Hess Thymic immunopathology after cyclosporin: effect of irradiation and age on medullary involution and recovery Transplant Proc 20 Suppl 3 1988 1072 1078
168. NH Fabien C Auger A Moriera JC. Monier Effects of cyclosporin A on mouse thymus: immunochemical and ultrastructural studies Thymus 20 1992 153 162
169. B Volc-Platzer K Rappersberger I Mosberger W Hinterberger W Emminger-Schmidmeier T Radaszkiewicz Sequential immunohistologic analysis of the skin following allogeneic bone marrow transplantation J Invest Dermatol 91 1988 162 168
170. B Volc-Platzer G. Stingl Cutaneous graft-versus-host disease SJ Burakoff HJ Deeg J Ferrara K Atkinson Graft-versus-host disease: immunology, pathophysiology, and treatment. 1990 Marcel Dekker New York 245 254
171. ML Dustin R Rothlein AK Bhan CA Dinarello TA. Springer Induction by IL-1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1) J Immunol 137 1986 245 254
172. P Miossec C Yu M. Ziff Lymphocyte chemotactic activity of human interleukin 1 J Immunol 133 1984 2007 2011
173. ML Dustin KH Singer DT Tuck TA. Springer Adhesion of T-lymphoblasts to epidermal keratinocytes is regulated by interferon-gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1) J Exp Med 167 1988 1323 1340
174. P-F Piguet GE Grau B Allet P. Vassalli Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-versus-host disease J Exp Med 166 1987 1280 1287
175. C Perreault M Pelletier D Landry M. Gyger Study of Langerhans cells after allogeneic bone marrow transplantation Blood 63 1984 807 811
176. M Pelletier C Perreault D Landry M David S. Montplaiser Ontogeny of human epidermal Langerhans cells Transplantation 38 1984 544 546
177. B Volc-Platzer G Stingl K Wolff W Hinterberger W. Schnedl Cytogenetic identification of allogeneic Langerhans cells in a bone-marrow-graft recipient N Engl J Med 310 1984 1123 1124
178. C Perreault M Pelletier R Belanger J Boileau Y Bonny M David Persistence of host Langerhans cells following allogeneic bone marrow transplantation: possible relationship with acute graft-versus-host disease Br J Haematol 60 1985 253 260
179. GF Murphy Y Merot AKF Tong B Smith MC. Mihm Depletion and repopulation of epidermal dendritic cells after allogeneic bone marrow transplantation in humans J Invest Dermatol 84 1985 210 214
180. AJ Suitters IA. Lampert The loss of Ia+ Langerhans cells during graft-versus-host disease in rats Transplantation 36 1983 540 546
181. + keratinocytes J Invest Dermatol 86 1986 226 234
182. B Dreno N Milpied JL Harousseau JF Stalder B Bureau B Milpied Cutaneous immunological studies in diagnosis of acute graft-versus-host disease Br J Dermatol 114 1986 7 15
183. SM Breathnach SI. Katz Immunopathology of cutaneous graft-versus-host disease Am J Dermatopathol 9 1987 343 348
184. D Niederweissen J Aubock J Troppmair M Herold G Schuler G Boeck Interferon-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses J Immunol 140 1988 2556 2564
185. M Imamura S Hashino S Kobayashi H Kobayashi J Tanaka K Imai Hyperacute graft-versus-host disease accompanied by increased serum IL-6 levels Int J Hematol 60 1994 85 89
186. M Imanura J Tanaka S Hashino H Kobayashi S Hirano T Minagawa Cytokines involved in graft-versus-host disease Hokkaido Igaku Zasshi 69 1994 1348 1353
187. HJ Deeg R. Storb Graft-versus-host disease: pathophysiological and clinical aspects Annu Rev Med 35 1984 11 24
188. ED Thomas R Storb RA Clift A Fefer L Johnson PE Neiman Bone-marrow transplantation (part 2) N Engl J Med 292 1975 895 902
189. H Glucksberg R Storb A Fefer CD Buckner PE Neiman RA Clift Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A matched sibling donors Transplantation 18 1974 295 304
190. ER Farmer AF. Hood Graft-versus-host disease TB Fitzpatrick AZ Eisen K Wolff Dermatology in general medicine. 1993 McGraw-Hill New York 1510 1519
191. GE Sale HM Shulman GB McDonald ED. Thomas Gastrointestinal graft-versus-host disease in man. A clinicopathological study of the rectal biopsy in man Am J Surg Pathol 3 1979 291 299
192. GB McDonald HM Shulman KM Sullivan GD. Spencer Intestinal and hepatic complications of human bone marrow transplantation (part 1) Gastroenterology 90 1986 460 477
193. GB McDonald HM Shulman KM Sullivan GD. Spencer Intestinal and hepatic complications of human bone marrow transplantation (part 2) Gastroenterology 90 1986 770 784
194. R. Storb Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings: beneficial effect of a protective environment N Engl J Med 308 1983 302 306
195. K. Atkinson Risk factors for and prevention of human chronic graft-versus-host disease SJ Burakoff HJ Deeg J Ferrara K Atkinson Graft-versus-host disease: immunology, pathophysiology, and treatment. 1990 Marcel Dekker New York 625 630
196. HJ Deeg R. Huss Acute graft-versus-host disease K Atkinson Clinical bone marrow transplantation. 1994 Cambridge University Press Cambridge 297 311
197. TD Horn JV Redd JE Karp WE Beschorner PJ Burke AF. Hood Cutaneous eruptions of lymphocyte recovery Arch Dermatol 125 1989 1512 1517
198. BK Yokel AF. Hood Mucocutaneous complications of antineoplastic therapy TB Fitzpatrick AZ Eisen K Wolff Dermatology in general medicine. 1993 McGraw-Hill New York 1795 1806
199. M-M Chren HM Lazarus DR Bickers CS. Landefeld Rashes in immunocompromised cancer patients: the diagnostic yield of skin biopsy and its effect on therapy Arch Dermatol 129 1993 175 181
200. J Osawa K Kitamura S Saito Z Ikezawa H. Nakajima Immunohistochemical study of graft-versus-host reaction (GVHR)-type drug eruptions J Dermatol 21 1994 25 30
201. K. Atkinson Clinical spectrum of human chronic graft- versus-host disease SJ Burakoff HJ Deeg J Ferrara K Atkinson Graft-versus-host disease: immunology, pathophysiology, and treatment. 1990 Marcel Dekker New York 569 586
202. K Atkinson MM Horowitz RP. Gale Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation Blood 75 1990 2459 2464
203. KM Sullivan RP Witherspoon R Storb P Weiden N Flournoy S. Dahlberg Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-versus-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation Blood 72 1988 546 554
204. HM Shulman GE Sale KG Lerner EA Barker PL Weiden K Sullivan Chronic cutaneous graft-versus-host disease in man Am J Pathol 91 1978 545 570
205. ER Farmer AF. Hood Graft-versus-host disease TB Fitzpatrick AZ Eisen K Wolff Dermatology in general medicine. 1986 McGraw-Hill New York 1344 1352
206. CS Freemer ER Farmer RL Corio VL Almonte JE Wagner GB Vogelsang Lichenoid graft-versus-host disease occurring in a dermatomal distribution Arch Dermatol 130 1994 70 72
207. JR Fenyk CM Smith PI Warkentin W Krivit RW Goltz JE Neely Sclerodermatous graft-versus-host disease limited to an area of measles exanthem Lancet 1 1978 472 473
208. FE Zwann J Jansen EM. Noorkijk Graft-versus-host disease limited to an area of irradiated skin Lancet 1 1980 1081 1082
209. ER Farmer AF. Hood Graft-versus-host disease TB Fitzpatrick AZ Eisen K Wolff Update: Dermatology in general medicine. 1983 McGraw-Hill New York 28 39
210. K Atkinson D Bryant W Delprado J. Biggs Widespread pulmonary fibrosis as a major clinical manifestation of chronic graft-versus-host disease Bone Marrow Transplant 4 1989 129 132
211. K. Atkinson Treatment of extensive human chronic graft- versus-host disease SJ Burakoff HJ Deeg J Ferrara K Atkinson Graft-versus-host disease: immunology, pathophysiology, and treatment. 1990 Marcel Dekker New York 681 690
212. AF Hood ER. Farmer Interface dermatitis ER Farmer AF Hood Pathology of the skin. 1990 Appleton & Lange Norwalk (CT) 110 127
213. DC. Snover The pathology of acute graft-versus-host disease SJ Burakoff HJ Deeg J Ferrara K Atkinson Graft-versus-host disease: immunology, pathophysiology, and treatment. 1990 Marcel Dekker New York 337 354
214. JM Esteban G. Somlo Skin biopsy in allogeneic and autologous bone marrow transplantation patients: a histologic and immunohistochemical study and review of the literature Mod Pathol 8 1995 59 64
215. GE Sale KG Lerner EA Barker HM Shulman ED. Thomas The skin biopsy in the diagnosis of acute graft-versus-host disease in man Am J Pathol 89 1977 621 634
216. KG Lerner GF Kao R Storb CD Buckner RA Clift ED. Thomas Histopathology of graft-versus-host reactions (GVHR) in human recipients of marrow from HL-A-matched sibling donors Transplant Proc 6 1974 367 371
217. WF Lever G. Schaumburg-Lever Histopathology of the skin 1990 JB Lippincott Philadelphia 138 139
218. R Storb HJ Deeg M Pepe F Appelbaum C Anasetti P Beatty Methotrexate and cyclosporin versus cyclosporin alone for the prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long term follow-up of a controlled trial Blood 73 1989 1729 1734
219. GB Vogelsang AD Hess AW Berkman PJ Tutschka ER Farmer PJ Converse An in vitro predictive test for graft-versus-host disease in patients with genotypic HLA-identical bone marrow transplants N Engl J Med 313 1985 645 650
220. M Theobold D Bunjes T Nierle R Arnold H. Heimpel Measurement of recipient-specific alloreactivity: Is GVHD predictable? Bone Marrow Transplant 12 Suppl 3 1993 S18 S23
221. AP Schwarer ZJ Yin PA Brookes AJ Barrett JR Batchelor JM Goldman Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone marrow transplantation Lancet 341 1993 203 205
222. O Ringden JH. Kersey Prevention and therapy of graft- versus-host disease. Report from a workshop Bone Marrow Transplant 10 Suppl 1 1992 S22 S24
223. SJ Forman KG Blume RA Krance PJ Miner GE Metter LR Hill A prospective randomized study of acute graft-versus-host disease in 107 patients with leukemia: methotrexate/prednisone versus cyclosporin A/prednisone Transplant Proc 19 1987 2605 2607
224. RA Nash R Etzion R Storb T Furlong T Gooley C Anasetti Tacrolimus (FK 506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single center study Blood 85 1995 3746 3753
225. KM Sullivan KJ Kopecky J Jocom L Fisher CD Buckner JD Meyers Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulins in bone marrow transplantation N Engl J Med 323 1990 705 712
226. KC Doney PL Weiden R Storb ED. Thomas Failure of early administration of anti-thymocyte globulin to lessen graft-versus-host disease in human allogeneic marrow transplant recipients Transplantation 31 1981 141 143
227. D Salzman F. LeMaistre Immunotoxins for the therapy of graft-versus-host disease Cancer Treat Res 68 1993 133 144
228. D Blaise D Maraninchi C Mawas AM Stoppa M Hirn D Guyotat Prevention of acute graft-versus-host disease by monoclonal antibody to interleukin 2 receptor Lancet 1 1989 1333 1334
229. C Belanger H Esperou-Bourdeau P Bordigoni JP Jouet G Souillet N Milpied Use of an anti-interleukin 2 receptor monoclonal antibody for GVHD prophylaxis in unrelated donor BMT Bone Marrow Transplant 11 1993 293 297
230. JA Bianco FR Appelbaum J Nemunaitis J Almgren F Andrews P Kettner Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation Blood 78 1991 1205 1211
231. RA Clift JA Bianco FR Appelbaum CD Buckner JW Singer L Bakke A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation Blood 82 1993 2025 2030
232. GB Vogelsang AD Hess GW. Santos Thalidomide for the treatment of graft-versus-host disease Bone Marrow Transplant 3 1988 393 398
233. D Heney CC Bailey IJ. Lewis Thalidomide in the treatment of graft-versus-host disease Biomed Pharma-cother 44 1990 199 204
234. T DeWitte A Schattenberg F Preijers R Raymakers P Muus J. Wessels Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation Bone Marrow Transplant 12 Suppl 3 1993 S2 S6
235. JH Antin BE Bierer BR Smith J Ferrara EC Guinan C Sieff Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies Blood 78 1991 2139 2149
236. RJ Soiffer J. Ritz Selective T-cell depletion of donor marrow with anti-CD6 monoclonal antibody: rationale and results Bone Marrow Transplantation 12 Suppl 3 1993 S7 S10
237. R Champlin S Giralt D Przepiorka W Ho K Lee J Gajewski Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease, and graft-versus-leukemia Prog Clin Biol Res 377 1992 385 394
238. LF Verdonck GC de Gast HG van Heugten AW Dekker A fixed low number of T-cells in HLA-identical allogeneic bone marrow transplantation Blood 75 1990 776 780
239. RJ Soiffer C Murray R Gonin J. Ritz Effect of low dose interleukin-2 on disease relapse after T-cell-depleted allogeneic bone marrow transplantation Blood 84 1994 964 971
240. KC. Anderson Autologous peripheral blood progenitor cell transplantation J Clin Apheresis 10 1995 131 138
241. DT Harris J Lo Cascio FJ. Besencon Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versus-host disease Bone Marrow Transplant 14 1994 545 553
242. C Almici C Carlo-Stella JE Wagner V. Rizzoli Umbilical cord blood as a source of hematopoietic stem cells: from research to clinical application Haematologica 80 1995 473 479
243. HJ. Deeg Ultraviolet irradiation in transplantation biology. Manipulation of immunity and immunogenicity Transplantation 45 1988 845 851
244. SF Oluwole K Engelstad T. James Prevention of graft- versus-host disease and marrow rejection: kinetics of induction of tolerance by UVB modulation of accessory cells and T cells in the bone marrow inoculum Blood 81 1993 1658 1665
245. JG Hudson M Lawler DH. Pamphilon Ultraviolet irradiation for the prevention of graft-versus-host disease and graft rejection in bone marrow transplantation Bone Marrow Transplant 14 1994 511 516
246. PJ Martin G Schoch L Fisher V Byers C Anasetti FR Appelbaum A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment Blood 76 1990 1464 1472
247. WI. Besinger Supportive care in marrow transplantation Curr Opin Oncol 4 1992 614 623
248. PJ. Henslee-Downey Treatment of acute graft-versus-host disease SJ Burakoff HJ Deeg J Ferrara K Atkinson Graft-versus-host disease: immunology, pathophysiology, and treatment. 1990 Marcel Dekker New York 487 497
249. PJ Martin G Schoch L Fisher V Byers FR Appelbaum GB McDonald A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment Blood 77 1991 1821 1828
250. R Storb E Gluckman ED Thomas CD Buckner RA Clift A Fefer Treatment of established graft-versus-host disease by antithymocyte globulin Blood 44 1974 57 75
251. A Kanamaru Y Takemoto E Kakishita H Dohy Y Kodera Y Moriyama FK 506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis therapy with cyclosporin and/or other immunosuppressants Bone Marrow Transplant 15 1995 885 889
252. MT Koehler D Howrie J Mirro S Neudorf J Blatt S Corey FK 506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation Bone Marrow Transplant 15 1995 895 899
253. H Hebart G Ehninger H Schmidt B Berner M Reuss-Borst HD Waller Treatment of steroid-resistant graft-versus-host disease after allogeneic bone marrow transplantation with anti-CD3/TCR monoclonal antibodies Bone Marrow Transplant 15 1995 891 894
254. E Racadot N Milpied P Bordigoni JY Cahn E Plouvier B Lioure Sequential use of three monoclonal antibodies in corticosteroid-resistant acute graft-versus-host disease: a multicenter pilot study including 15 patients Bone Marrow Transplant 15 1995 669 677
255. JH Antin HJ Weinstein EC Guinan P McCarthy BE Bierer DG Gilliland Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease Blood 84 1994 1342 1348
256. PL McCarthy S Abhyankar S Neben G Newman C Sieff RC Thompson Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease Blood 78 1991 1915 1918
257. T Eppinger G Ehninger M Steinert D Niethammer R. Dopfer 8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease Transplantation 50 1990 807 811
258. S Reinauer P Lehmann G Plewig A Heyll D Sohngen E. Holzle Photochemotherapy (PUVA) of acute graft-versus-host disease Hautarzt 44 1993 708 712
259. KM Sullivan HM Shulman R Storb HG Deeg S Dahlberg JE Sanders Alternating day cyclosporin and prednisone for treatment of high risk chronic graft-versus-host disease Blood 72 1988 555 561
260. GB Vogelsang ER Farmer AD Hess V Altamonte WE Beschorner DA Jabs Thalidomide for the treatment of chronic graft-versus-host disease N Engl J Med 326 1992 1055 1058
261. CH Cole PC Rogers S Pritchard G Phillips KW. Chan Thalidomide in the management of chronic graft-versus-host disease in children following bone marrow transplantation Bone Marrow Transplant 14 1994 937 942
262. PM Parker N Chao A Nademanee MR O'Donnell GM Schmidt DS Snyder Thalidomide as salvage therapy for chronic graft-versus-host disease Blood 86 1995 3604 3609
263. N Kapoor AE Pelligrini EA Copelan I Cunningham BR Avalos JL Klein Psoralen plus ultraviolet A (PUVA) in the treatment of chronic graft-versus-host disease: preliminary experience in standard treatment resistant patients Semin Hematol 29 1992 108 112
264. M Owsianowski H Gollnick W Siegert R Schwerdtfeger CE. Orfanos Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis Bone Marrow Transplant 14 1994 845 848
265. A Nagler V Segal S Slavin F. Levi-Schaffer Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblasts Clin Exp Immunol 100 1995 529 535
266. GP Summerfield AJ Bellingham C Bunch JC. Woodrow Successful treatment of chronic graft-versus-host disease with penicillamine Clin Lab Haematol 5 1983 313 318
267. HY Knobler U Sagher IJ Peled MR Wexler D Steiner N Rubinstein Tolerance to donor type skin in the recipients of bone marrow allografts: treatment of skin ulcers in chronic graft-versus-host disease with skin from the bone marrow donor Transplantation 40 1985 223 225
268. Y Kamei S Torii M Hasegawa K Toriyama Y. Kodera Simultaneous allografting and autografting of skin for ulcers in a bone marrow transplant patient Transplantation 56 1993 1530 1531
269. S Kondo K Tamura S Makino Y. Takamatsu Allogeneic skin grafting for extensive skin chronic graft-versus-host disease Int J Hematol 60 1994 151 155
270. JB Epstein DE. Reece Topical cyclosporin A for treatment of oral chronic graft-versus-host disease Bone Marrow Transplant 13 1994 81 86